REMSleep Holdings, Inc. (RMSL) Stock
REMSleep Holdings, Inc. is an enterprise globally focused on crafting and providing solutions for individuals afflicted with sleep apnea.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About REMSleep Holdings, Inc.
REMSleep Holdings, Inc. is an enterprise globally focused on crafting and providing solutions for individuals afflicted with sleep apnea. Among its key offerings is the DeltaWave CPAP interface device, specifically engineered to aid in the treatment of patients suffering from this condition. The company caters to a broad spectrum of clients, including home healthcare providers, independent sleep clinics, direct consumers, medical practitioners, group medical organizations, hospitals, and various professional medical associations. Its corporate headquarters are situated in Tampa, Florida.
REMSleep Holdings, Inc. (RMSL) stock trades at $0.00 with a market capitalization of $2.71M. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of -22.07, price-to-sales of 162.15. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.
On profitability, REMSleep Holdings, Inc. generates an operating margin of -17150.92%, a net profit margin of 0.00%.
Official website: remsleep.com